Icahn's Group Reportedly To Get 2 of The 4 Biogen Idec (BIIB) Board Seats

June 3, 2009 1:53 PM EDT

Icahn representative said it appears they have won 2 of the 4 board seats they were seeking at Biogen Idec (Nasdaq: BIIB).


Related Categories

Corporate News
Management Changes

Stocks Mentioned

BIIB 45.41

+0.00 +0.00%
Volume: 4,801,707
Track BIIB


Related Entities


Add Your Comment